Displaying results 25 - 36 of 70
Public Health and Advocacy
EASL Policy Statement on Hepatitis C Elimination - RU

EASL Policy Statement on Hepatitis C Elimination - RU

PDF
View
Public Health and Advocacy
EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF
View
Public Health and Advocacy
EASL Policy Statement: Reducing alcohol harms

EASL Policy Statement: Reducing alcohol harms

PDF
View
Public Health and Advocacy
EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues
View
Public Health and Advocacy
EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues
View
Liver Tumours
EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio
View
Metabolism, Alcohol & Toxicity

Introduction and presentation of the NAFLD patient guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

The user perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the models of care

Webcasts
View
Metabolism, Alcohol & Toxicity

A practical example from the guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

A multidisciplinary patient-centred approach

Webcasts
View